Intesa Sanpaolo Posts Profit Beat on Rates Boost, Backs Guidance
By Elena Vardon
Intesa Sanpaolo backed its profit guidance for 2024 as it reported better-than-expected first-quarter results driven by higher interest income.
The Italian bank on Friday reported a net income, or net profit, of 2.30 billion euros ($2.47 billion) for the three months ended March 31, compared with EUR1.96 billion in the year-earlier period.
Operating income--the lender's top-line figure--rose to EUR6.73 billion from EUR6.06 billion, it said. The result was boosted by a 21% on-year jump in net interest income--the difference between what banks earn on loans and what they pay clients for deposits--to EUR3.93 billion while fee and commission income also rose 6.3% to EUR2.27 billion.
A consensus compiled by Visible Alpha based on 11 analyst estimates expected net income of EUR2.17 billion and total revenue of EUR6.63 billion.
The Turin-based group confirmed that it expects net income to be over EUR8.0 billion for 2024 and for 2025.
Write to Elena Vardon at elena.vardon@wsj.com
(END) Dow Jones Newswires
May 03, 2024 07:14 ET (11:14 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks